Qunibi W Y, al-Sibai M B, Taher S, Harder E J, de Vol E, al-Furayh O, Ginn H E
Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Q J Med. 1990 Oct;77(282):1039-60. doi: 10.1093/qjmed/77.1.1039.
During a nine-year period, 14 cases of mycobacterial infection (tuberculosis) developed in 403 renal transplant recipients at the King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia, an incidence of 3.5 per cent. The annual incidence of tuberculosis was about 50 times higher than that in the general population. Infection was disseminated in nine (64.3 per cent), pulmonary in four (28.6 per cent), and genitourinary in 1 (7.1 per cent). In one patient tuberculosis was transmitted by the donor's kidney. The clinical manifestations were often ill-defined and not different from that in the normal host. Cultures from all patients grew Mycobacterium tuberculosis; concomitant infection with other organisms was present in five patients (35.7 per cent). Two of 18 patients (group 1) with positive pretransplant tuberculin skin test developed tuberculosis after transplantation (11 per cent), and neither received isoniazid prophylaxis; three of 70 patients (group 2) with negative skin tests developed tuberculosis after transplantation (4.3 per cent). The difference between the two groups was not statistically significant. Review of all published cases of mycobacterial infections in renal transplant recipients revealed 130 cases. Tuberculosis was disseminated in 38.7 per cent, pulmonary in 40.2 per cent, cutaneous in 12 per cent, and miscellaneous in 9.4 per cent. Atypical mycobacteria were responsible for 29 per cent of disseminated infections, 8 per cent of pulmonary infections and all cases of cutaneous and articular tuberculosis. Invasive procedures were needed to establish the diagnosis in 21 of 33 disseminated cases but in only three of 47 cases of pulmonary tuberculosis (p less than 0.0001). The mortality rate from disseminated disease was 37 per cent and from all other forms of tuberculosis was 11 per cent (p less than 0.005). These findings (1) confirm the higher incidence of tuberculosis in renal transplant recipients, compared to the general population; (2) suggest that pretransplant skin testing probably has little value in identifying patients at risk; (3) show that disseminated tuberculosis is common after renal transplantation and requires invasive procedures for diagnosis; (4) confirm that the donor kidney may be an important source of infection; and (5) indicate that concomitant infection with other organisms is common.
在沙特阿拉伯利雅得的法赫德国王专科医院及研究中心,403名肾移植受者在9年期间发生了14例分枝杆菌感染(结核病),发病率为3.5%。结核病的年发病率比普通人群高约50倍。感染播散型的有9例(64.3%),肺部感染4例(28.6%),泌尿生殖系统感染1例(7.1%)。1例患者的结核病是由供体肾脏传播的。临床表现往往不明确,与正常宿主无异。所有患者的培养物均生长出结核分枝杆菌;5例患者(35.7%)合并有其他病原体感染。18例移植前结核菌素皮肤试验阳性的患者(第1组)中有2例在移植后发生了结核病(11%),且均未接受异烟肼预防治疗;70例皮肤试验阴性的患者(第2组)中有3例在移植后发生了结核病(4.3%)。两组之间的差异无统计学意义。对所有已发表的肾移植受者分枝杆菌感染病例进行回顾,共发现130例。播散型结核病占38.7%,肺部结核病占40.2%,皮肤结核病占12%,其他类型占9.4%。非典型分枝杆菌导致了29%的播散型感染、8%的肺部感染以及所有皮肤和关节结核病例。33例播散型病例中有21例需要通过侵入性检查来确诊,但47例肺结核病例中只有3例需要(P<0.0001)。播散型疾病的死亡率为37%,其他所有类型结核病的死亡率为11%(P<0.005)。这些发现(1)证实肾移植受者中结核病的发病率高于普通人群;(2)提示移植前皮肤试验在识别高危患者方面可能价值不大;(3)表明肾移植后播散型结核病很常见,且需要通过侵入性检查来诊断;(4)证实供体肾脏可能是重要的感染源;(5)表明合并其他病原体感染很常见。